This site is intended for healthcare professionals only

Diabetes Distilled review of the year: Key topic 1

The incretin “controversy”: A TV documentary and a BMJ article suggested there might be an increased risk of pancreatitis and pancreatic cancer with incretin-based drugs. A statement from the PCDS Committee, later reinforced by the European Medicines Agency, set the risks in context.

By Colin Kenny, GP, County Down

The increased risk of pancreatitis in people receiving glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes has been known for several years and is reflected in current summaries of product characteristics. The possible risk of pancreatic cancer discussed in the Channel 4 documentary and the BMJ article was based on pancreatic-duct metaplasia seen in donor organs but not replicated in clinical trials.

The PCDS Committee advised that healthcare professionals make no changes to their current practice in relation to these agents. The European Medicines Agency (EMA), the US Food and Drug Administration and the Medicines and Healthcare products Regulatory Agency have made similar recommendations (referenced in the statement linked below). The Committee reflected that the potential link between these therapies and pancreatitis has been known for several years. Current EMA advice is that these drugs remain available as treatments to patients within the NHS.

Link to original PCDS statement.

Related content
Hypoglycaemia awareness resources for healthcare professionals
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.